The influence of different sample collection types on the levels of markers used for Down's syndrome screening as measured by the Kryptor Immunosassay system.
Spencer K
Purpose
Conclusion
Studies (1)
Purpose
The purpose of this study was to determine whether plasma could be used instead of maternal serum for measurement of AFP, PAPP-A, and free beta-hCG during prenatal screening for Downs syndrome. All specimens were refrigerated.
Summary of Findings
Free beta-hCG measurements were not significantly different between serum and heparinized, citrated or EDTA-plasma. However, AFP levels were significantly reduced in citrated and EDTA-plasma compared to serum levels. Furthermore, significantly lower PAPP-A values were obtained from plasma collected with any of the three anticoagulants when compared to levels obtained from serum suggesting that serum must be used for measurement of these three maternal biochemical markers of Downs syndrome.
Biospecimens
FluidPlasmaFluidSerumFluidBloodPreservation Types
Other PreservativeDiagnoses
PregnantPlatforms
GlycoproteinHematology/ auto analyzerProteinHematology/ auto analyzerPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Biospecimen Acquisition Anticoagulant Lithium heparinNonePotassium EDTASodium citrateBiospecimen Aliquots and Components Blood and blood products PlasmaSerum